Charged Alpha
CHARGED ALPHA · RESEARCH PACKET
Companion to the Q3 2026 earnings episode · published October 8, 2026

PEP Stock: The Refund Behind the Profit Growth

PepsiCo, Inc. · Nasdaq: PEPQuarter ended September 5, 2026Results October 8, 2026 (before market open; approximately 5 a.m. Central was announced, exact release clock not confirmed)Consumer staplesPresented by Hudson & Lana
HOLDConviction 3 / 5Uncertainty: Medium
Fair value (base)$135.00range $110.00–$160.00
Price, Oct 8, 9:43 a.m. CDT intraday$126.43+7% to base
Probability-weighted$135.00+7% expected

International growth and the dividend support patience. But a tariff refund exceeded the entire quarterly increase in core operating profit, while North America needs more investment and the earnings outlook fell. Our three valuation routes cluster near $132–$134, supporting a rounded $135 anchor. At the observed price, the upside is too small for a fresh BUY with medium uncertainty. We would revisit near $115 if the business case remains intact.

Layer 1 · fast

The 60-second read

Revenue$25.274bn+5.6% reported
Organic growth3.1%International 8%
Core EPS$2.34+2%; GAAP +17%
Core margin16.9%Company reports −35 bps
Tariff refund$178mCore profit growth was $140m
Core CC outlook+1% to +2%Cut from low end of +4–6%
Annual dividend$5.924.68% indicated yield, computed
Net debt$40.718bnCash plus short-term investments offset debt

Five things to know

  1. The headline overstates the operating improvement. Core EPS rose 2% while GAAP EPS increased 17%; the prior-year adjustment burden was much larger.
  2. The refund matters. Subtracting the disclosed $178m tariff refund from $4.277bn core profit gives $4.099bn, below last year’s $4.137bn. This is our diagnostic, not an issuer measure.
  3. International is doing the heavy lifting. Organic revenue grew 8% and core operating margin expanded 105 basis points.
  4. The domestic repair costs money. North America food core margin fell 280 basis points as affordability and marketing investment outweighed savings.
  5. Price offers income, but limited cushion. HOLD, conviction 3/5, $135 fair value; a $115 entry would create about 15% margin to that anchor.
Layer 1 · the call

Three scenarios, one probability-weighted number

Twelve-month valuation cases, explicitly judgmental

Values depend on operating repair · Scenario probabilities and multiples are Charged Alpha assumptions, not company guidance.
BearBear: $110.00$110.00BaseBase: $135.00$135.00BullBull: $160.00$160.00WeightedWeighted: $135.00$135.00Observed priceObserved price: $126.43$126.43
BearBear: $110.00$110.00BaseBase: $135.00$135.00BullBull: $160.00$160.00WeightedWeighted: $135.00$135.00Observed priceObserved price: $126.43$126.43
Show the data
CaseProbabilityValue
Bear25%110
Base50%135
Bull25%160
ScenarioProbability12-month valuevs $126.43What has to happenThe arithmetic
Bear25%$110.00−13%North America remains weak; reinvestment fails to restore margins.$8.00 prospective core EPS × 13.75 = $110.
Base50%$135.00+7%International growth offsets a slow domestic repair.Three independent assumptions converge near $132–$134; rounded editorial anchor $135.
Bull25%$160.00+27%Volume and domestic profit recover together.$8.80 prospective core EPS × 18.18 ≈ $160.
Weighted value = 25% × $110 + 50% × $135 + 25% × $160 = $135. This is not a guaranteed return or a probability inferred from option prices.
Layer 1 · falsifiable

Signposts: what would change our mind

SignpostNow (Q3 2026)Green ifRed ifNext check
North America food margin21.2% core; −280 bps YoYDecline narrows to ≤100 bpsDecline stays >200 bpsQ4 2026 results; date unconfirmed
PBNA organic growthSlight decline; rounded 0%At least +2%Below 0%Q4 2026 results
International growth8% organicAt least 6% with margin expansionBelow 4%Q4 2026 results
Recurring operating profitRefund-adjusted Q3 −0.9% computedPositive growth excluding similar creditsAnother negative quarterQ4 2026 results
EPS guidance credibility2026 core CC +1% to +2%Meets range without another cutBelow +1%FY2026 results, expected early 2027
Cash funding2025 issuer FCF $8.2bn; returns $8.638bnFCF covers all cash returnsMore than $1bn funding gapFY2026 cash flow
Entry discipline$126.43 observed; $135 fair value$115 or lower with thesis intactValue falls below observed priceEach quarterly review

These are prospective decision thresholds. This is our first packet for this exact PepsiCo period; there is no prior packet scorecard to manufacture.

The tape and the price

PepsiCo traded at $126.43 in the retained quote at 9:43 a.m. Central on October 8. That observation was about 2.18% above the previous close. It is an intraday observation, not the completed earnings-day return. The chart deliberately ends with the October 7 close; including a changing provider “close” during the session would mix two different measurements. A falling share price can improve valuation without proving that the operating problems are solved.

The company is a mature global food-and-beverage franchise, but the stock still represents a claim on future cash generation after reinvestment. Its indicated dividend yield is attractive relative to its own growth pace. That is a reason to examine funding carefully, rather than assuming the dividend makes the equity bond-like. The same affordability investments that can defend volumes may reduce the cash available for future dividend growth.

Prior earnings reactions have gone in both directions. The historical bars measure the release-day close against the preceding trading close for before-open prints. They are descriptive, not evidence that earnings alone caused each move. We retain the current release as an incomplete row in the dataset and do not substitute the morning move for its final reaction. Market and consensus data were collected during this research session; their underlying analyst judgments may still predate the guidance cut.

Quote$126.43
Quote timeOct 8 09:43 CDT
Market cap$172.7bn
Enterprise value$213.4bn
52-week high$171.48
52-week low$123.47
Beta0.364
Float1,359.6m
Diluted shares1,367m quarterly average
Net debt$40.718bn
Core EPS guide midpoint$8.38 computed
Forward core P/E15.1×
Annualized dividend$5.92
Indicated yield4.68%
Our fair value$135
Conviction3/5
Completed closes versus fair value · FMP daily data through Oct 7; reference levels are our assumptions.
$100.00$120.00$140.00$160.00$180.00$135 fair value$115 entry checkpointJul 25Sep 25Dec 25Mar 26Jun 26Sep 26$123.73
$100.00$120.00$140.00$160.00$180.00$135 fair value$115 entry checkpointJul 25Sep 25Dec 25Mar 26Jun 26Sep 26$123.73
Show the data
DateClose
2025-07-01135.26
2025-07-30142.86
2025-08-27147.64
2025-09-25139.92
2025-10-23151.51
2025-11-20146.10
2025-12-19148.16
2026-01-21146.74
2026-02-19164.59
2026-03-19152.74
2026-04-17157.67
2026-05-15149.12
2026-06-15146.25
2026-07-15135.40
2026-08-12138.70
2026-09-10136.65
Eight completed print-day reactions · Computed close-to-close moves. Oct 8, 2026 remains incomplete.
−10−505102024-10-08 · Eight completed print-day reactions: 1.9%2025-02-04 · Eight completed print-day reactions: −4.5%2025-04-24 · Eight completed print-day reactions: −4.9%2025-07-17 · Eight completed print-day reactions: 7.5%2025-10-09 · Eight completed print-day reactions: 4.2%2026-02-03 · Eight completed print-day reactions: 4.9%2026-04-16 · Eight completed print-day reactions: 2.3%2026-07-09 · Eight completed print-day reactions: −3.3%−3.3%2024-10-082025-02-042025-04-242025-07-172025-10-092026-02-032026-04-162026-07-09
−10−505102024-10-08 · Eight completed print-day reactions: 1.9%2025-02-04 · Eight completed print-day reactions: −4.5%2025-04-24 · Eight completed print-day reactions: −4.9%2025-07-17 · Eight completed print-day reactions: 7.5%2025-10-09 · Eight completed print-day reactions: 4.2%2026-02-03 · Eight completed print-day reactions: 4.9%2026-04-16 · Eight completed print-day reactions: 2.3%2026-07-09 · Eight completed print-day reactions: −3.3%−3.3%2024-10-082025-02-042025-04-242025-07-172025-10-092026-02-032026-04-162026-07-09
Show the data
PeriodValue
2024-10-081.92
2025-02-04−4.51
2025-04-24−4.89
2025-07-177.45
2025-10-094.23
2026-02-034.93
2026-04-162.28
2026-07-09−3.26

The print: growth without full leverage

Revenue increased 5.6% to $25.274 billion. The issuer attributes the reported increase to 3.1% organic growth, a 1.7 percentage-point acquisition and divestiture contribution, and a 0.7-point currency benefit; rounding prevents these components from being a perfect additive bridge. Organic improvement is real, but buying revenue and translating foreign sales at favorable exchange rates are different from selling more product profitably.

Core EPS of $2.34 exceeded the retained provider consensus of $2.29, while sales exceeded its $24.953 billion estimate. Those are approximately 2.2% and 1.3% beats respectively, computed on comparable core EPS and revenue. A beat against a short-term estimate can coexist with a lower annual outlook. Here the updated guidance is more consequential than the narrow beat: full-year core constant-currency EPS growth is now 1%–2%, replacing the low end of the earlier 4%–6% range.

The core US-dollar EPS growth range fell to 2.5%–3.5% from the low end of 5%–7%. The tax assumption improved to approximately 21% from 22%, and expected currency assistance increased to about 1.5%. Those helps make the underlying domestic margin shortfall harder to dismiss. Revenue guidance of about 6% is stronger in reported terms, but organic guidance of about 3% sits within the earlier 2%–4% range. This is not an across-the-board demand collapse; it is a profitability conversion problem.

Metric ($m except EPS)Q3 2026Q3 2025Q2 2026
Revenue25,274.0023,937.0024,181.00
GAAP operating profit4,260.003,569.004,023.00
Core operating profit4,277.004,137.004,067.00
GAAP EPS2.231.902.18
Core EPS2.342.292.20
Primary issuer releases. Quarter lengths and seasonality matter; sequential comparisons are not annual growth.
Nine quarters of reported sales
010.0K20.0K30.0K40.0KQ3 2024 · Nine quarters of reported sales: $23,319MQ4 2024 · Nine quarters of reported sales: $27,784MQ1 2025 · Nine quarters of reported sales: $17,919MQ2 2025 · Nine quarters of reported sales: $22,726MQ3 2025 · Nine quarters of reported sales: $23,937MQ4 2025 · Nine quarters of reported sales: $29,343MQ1 2026 · Nine quarters of reported sales: $19,443MQ2 2026 · Nine quarters of reported sales: $24,181MQ3 2026 · Nine quarters of reported sales: $25,274M$25,274MQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
010.0K20.0K30.0K40.0KQ3 2024 · Nine quarters of reported sales: $23,319MQ4 2024 · Nine quarters of reported sales: $27,784MQ1 2025 · Nine quarters of reported sales: $17,919MQ2 2025 · Nine quarters of reported sales: $22,726MQ3 2025 · Nine quarters of reported sales: $23,937MQ4 2025 · Nine quarters of reported sales: $29,343MQ1 2026 · Nine quarters of reported sales: $19,443MQ2 2026 · Nine quarters of reported sales: $24,181MQ3 2026 · Nine quarters of reported sales: $25,274M$25,274MQ32024Q42024Q12025Q22025Q32025Q42025Q12026Q22026Q32026
Show the data
PeriodValue
Q3 202423,319.00
Q4 202427,784.00
Q1 202517,919.00
Q2 202522,726.00
Q3 202523,937.00
Q4 202529,343.00
Q1 202619,443.00
Q2 202624,181.00
Q3 202625,274.00
Reported versus core operating profit · Primary as reported in each original release; core is issuer non-GAAP.
GAAPCore
02,0004,0006,000Q3 2024 · GAAP: $3,872MQ3 2024 · Core: $4,176MQ4 2024 · GAAP: $2,250MQ4 2024 · Core: $3,462MQ1 2025 · GAAP: $2,583MQ1 2025 · Core: $2,789MQ2 2025 · GAAP: $1,789MQ2 2025 · Core: $3,911MQ3 2025 · GAAP: $3,569MQ3 2025 · Core: $4,137MQ4 2025 · GAAP: $3,557MQ4 2025 · Core: $4,075MQ1 2026 · GAAP: $3,213MQ1 2026 · Core: $3,050MQ2 2026 · GAAP: $4,023MQ2 2026 · Core: $4,067MQ3 2026 · GAAP: $4,260M$4,260MQ3 2026 · Core: $4,277M$4,277MQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
02,0004,0006,000Q3 2024 · GAAP: $3,872MQ3 2024 · Core: $4,176MQ4 2024 · GAAP: $2,250MQ4 2024 · Core: $3,462MQ1 2025 · GAAP: $2,583MQ1 2025 · Core: $2,789MQ2 2025 · GAAP: $1,789MQ2 2025 · Core: $3,911MQ3 2025 · GAAP: $3,569MQ3 2025 · Core: $4,137MQ4 2025 · GAAP: $3,557MQ4 2025 · Core: $4,075MQ1 2026 · GAAP: $3,213MQ1 2026 · Core: $3,050MQ2 2026 · GAAP: $4,023MQ2 2026 · Core: $4,067MQ3 2026 · GAAP: $4,260M$4,260MQ3 2026 · Core: $4,277M$4,277MQ32024Q42024Q12025Q22025Q32025Q42025Q12026Q22026Q32026
Show the data
QuarterGAAP $mCore $m
q3-20243,8724,176
q4-20242,2503,462
q1-20252,5832,789
q2-20251,7893,911
q3-20253,5694,137
q4-20253,5574,075
q1-20263,2133,050
q2-20264,0234,067
q3-20264,2604,277
2026 guidanceCurrentPrevious
Organic revenueAbout +3%+2% to +4%
Net revenueAbout +6%+4% to +6%
Core CC EPS+1% to +2%Low end of +4% to +6%
Core USD EPS+2.5% to +3.5%Low end of +5% to +7%
Core tax rateAbout 21%About 22%
Cash returns$8.9bn$8.9bn

International offsets domestic pressure

The international engine deserves credit. Organic revenue grew 8%, core operating profit increased 16%, and core margin expanded 105 basis points. Management says international operations supplied 41% of year-to-date revenue and 45% of core segment operating profit. That profit share excludes corporate unallocated costs, so it is not interchangeable with a consolidated margin contribution. A geographically diverse brand portfolio can cushion a weak domestic cycle without making the domestic problem disappear.

Foods North America generated $6.504 billion of revenue, almost unchanged from $6.526 billion. Core operating profit fell to $1.382 billion from $1.570 billion. Management attributes the 280-basis-point margin decline to affordability investment, the lap of an asset-sale gain and higher advertising, partly offset by productivity and organic volume growth. Improving unit movement through cheaper packs or better value is useful, but investors need the next stage: stable pricing economics and profit conversion.

Beverages North America grew reported sales 5%, primarily because of acquisitions. Its organic revenue declined slightly, while the release rounds the headline rate to zero. The organic-volume revenue bridge shows a decline of 3%, versus a different physical-volume definition in the summary table. We preserve that distinction rather than blending the measures. Core profit increased 4%, but margin declined 15 basis points. Tariff refunds helped offset mix, volume and marketing pressure.

The international franchise business differs economically from owned bottling: concentrate shipments drive its recognized revenue, while retail case sales include activity outside consolidated revenue. Neither an impressive physical-volume statistic nor a brand’s retail-sales estimate should be dropped into the consolidated sales model. The packet uses reported segment dollars for valuation and treats operating volume as a directional signpost.

Q3 2026 segment revenue
02,5005,0007,50010.0KPFNA · Q3 2026 segment revenue: $6,504MPBNA · Q3 2026 segment revenue: $7,706MIB Franchise · Q3 2026 segment revenue: $1,401MEMEA · Q3 2026 segment revenue: $5,413MLatAm Foods · Q3 2026 segment revenue: $3,021MAsia Pacific Foods · Q3 2026 segment revenue: $1,229M$1,229MPFNAPBNAIB FranchiseEMEALatAm FoodsAsia Pacific Foods
02,5005,0007,50010.0KPFNA · Q3 2026 segment revenue: $6,504MPBNA · Q3 2026 segment revenue: $7,706MIB Franchise · Q3 2026 segment revenue: $1,401MEMEA · Q3 2026 segment revenue: $5,413MLatAm Foods · Q3 2026 segment revenue: $3,021MAsia Pacific Foods · Q3 2026 segment revenue: $1,229M$1,229MPFNAPBNAIBFranchiseEMEALatAmFoodsAsiaPacificFoods
Show the data
PeriodValue
PFNA6,504.00
PBNA7,706.00
IB Franchise1,401.00
EMEA5,413.00
LatAm Foods3,021.00
Asia Pacific Foods1,229.00
Q3 2026 segment core profit · Corporate unallocated core expense of $426m excluded from these business bars, included in consolidated profit.
05001,0001,5002,000PFNA · Q3 2026 segment core profit: $1,382MPBNA · Q3 2026 segment core profit: $1,012MIB Franchise · Q3 2026 segment core profit: $564MEMEA · Q3 2026 segment core profit: $940MLatAm Foods · Q3 2026 segment core profit: $626MAsia Pacific Foods · Q3 2026 segment core profit: $179M$179MPFNAPBNAIB FranchiseEMEALatAm FoodsAsia Pacific Foods
05001,0001,5002,000PFNA · Q3 2026 segment core profit: $1,382MPBNA · Q3 2026 segment core profit: $1,012MIB Franchise · Q3 2026 segment core profit: $564MEMEA · Q3 2026 segment core profit: $940MLatAm Foods · Q3 2026 segment core profit: $626MAsia Pacific Foods · Q3 2026 segment core profit: $179M$179MPFNAPBNAIBFranchiseEMEALatAmFoodsAsiaPacificFoods
Show the data
PeriodValue
PFNA1,382.00
PBNA1,012.00
IB Franchise564.00
EMEA940.00
LatAm Foods626.00
Asia Pacific Foods179.00
Domestic and international core profit
$0M$500M$1,000M$1,500M$2,000MPFNAQ3 2025: $1,570MQ3 2026: $1,382M$1,382MPBNAQ3 2025: $975MQ3 2026: $1,012M$1,012MIB FranchiseQ3 2025: $511MQ3 2026: $564M$564MEMEAQ3 2025: $808MQ3 2026: $940M$940MLatAm FoodsQ3 2025: $523MQ3 2026: $626M$626MAsia Pacific FoodsQ3 2025: $156MQ3 2026: $179M$179M
$0M$500M$1,000M$1,500M$2,000MPFNAQ3 2025: $1,570MQ3 2026: $1,382M$1,382MPBNAQ3 2025: $975MQ3 2026: $1,012M$1,012MIB FranchiseQ3 2025: $511MQ3 2026: $564M$564MEMEAQ3 2025: $808MQ3 2026: $940M$940MLatAm FoodsQ3 2025: $523MQ3 2026: $626M$626MAsia Pacific FoodsQ3 2025: $156MQ3 2026: $179M$179M
Show the data
Segment2025 $m2026 $m
PFNA1570.01382.0
PBNA975.01012.0
IB Franchise511.0564.0
EMEA808.0940.0
LatAm Foods523.0626.0
Asia Pacific Foods156.0179.0
Organic volume contribution to revenue · Issuer A-7 organic-volume revenue bridge. Not identical to physical-volume summary definitions.
−5051015PFNA · Organic volume contribution to revenue: 0.5%PBNA · Organic volume contribution to revenue: −3.0%IB Franchise · Organic volume contribution to revenue: 5.5%EMEA · Organic volume contribution to revenue: 1.0%LatAm Foods · Organic volume contribution to revenue: 2.5%Asia Pacific Foods · Organic volume contribution to revenue: 11.0%11.0%PFNAPBNAIB FranchiseEMEALatAm FoodsAsia Pacific Foods
−5051015PFNA · Organic volume contribution to revenue: 0.5%PBNA · Organic volume contribution to revenue: −3.0%IB Franchise · Organic volume contribution to revenue: 5.5%EMEA · Organic volume contribution to revenue: 1.0%LatAm Foods · Organic volume contribution to revenue: 2.5%Asia Pacific Foods · Organic volume contribution to revenue: 11.0%11.0%PFNAPBNAIBFranchiseEMEALatAmFoodsAsiaPacificFoods
Show the data
PeriodValue
PFNA0.50
PBNA−3.00
IB Franchise5.50
EMEA1.00
LatAm Foods2.50
Asia Pacific Foods11.00

Follow the dollars below the headline

Core operating profit was $4.277 billion versus $4.137 billion a year ago, a $140 million increase. The current quarter includes $178 million of tariff refunds. Removing that disclosed benefit produces $4.099 billion, about 0.9% below the prior-year core figure. This is a transparent sensitivity calculation, not an issuer-defined recurring-profit measure or a complete like-for-like adjustment. The prior year also contained an asset-sale benefit within North America foods, so this diagnostic cannot isolate every moving part. It does establish that the headline increase is smaller than a single identified current-period benefit.

GAAP operating profit was $4.260 billion. Starting from core, adding $79 million of commodity-mark gains, subtracting $192 million of restructuring charges and adding $96 million of acquisition-related net credits reconciles the total. The small net difference conceals large gross adjustments. Acquisition credits can improve reported income when expected contingent payments fall; they do not necessarily indicate better acquired-business performance.

Below operations, pension and retiree medical expense of $114 million and net interest and other expense of $242 million brought pretax income to $3.904 billion. Taxes of $834 million and minority income of $22 million left $3.048 billion attributable to PepsiCo. The minority claim is small; financing costs and business profitability dominate the investment question. Year-to-date reported growth is additionally flattered by the absence of large prior-year intangible impairments. Core profit offers a useful comparison, but it still includes the tariff benefit and ordinary reinvestment costs.

Q3 core profit to common-shareholder income
02,0004,0006,000Core operating: $4,277M$4,277MCoreoperatingCommodity marks: $79M$79MCommoditymarksRestructuring: −$192M−$192MRestructuringAcquisition credits: $96M$96MAcquisitioncreditsGAAP operating: $4,260M$4,260MGAAPoperatingPension: −$114M−$114MPensionInterest/other: −$242M−$242MInterest/otherTax: −$834M−$834MTaxMinorities: −$22M−$22MMinoritiesParent income: $3,048M$3,048MParentincome
02,0004,0006,000Core operating: $4,277M$4,277MCore operatingCommodity marks: $79M$79MCommodity marksRestructuring: −$192M−$192MRestructuringAcquisition credits: $96M$96MAcquisition creditsGAAP operating: $4,260M$4,260MGAAP operatingPension: −$114M−$114MPensionInterest/other: −$242M−$242MInterest/otherTax: −$834M−$834MTaxMinorities: −$22M−$22MMinoritiesParent income: $3,048M$3,048MParent income
Show the data
Bridge item$m
Core operating4277
Commodity marks79
Restructuring−192
Acquisition credits96
GAAP operating4260
Pension−114
Interest/other−242
Tax−834
Minorities−22
Parent income3048
The refund is larger than the growth · Computed difference versus management-disclosed refund; not a replacement non-GAAP measure.
Core profit increaseCore profit increase: $140M$140MTariff refundTariff refund: $178M$178M
Core profit increaseCore profit increase: $140M$140MTariff refundTariff refund: $178M$178M
Show the data
Item$m
Core operating profit YoY change140
Current tariff refund178
PeriodGAAP operatingCore operatingParent income
Q3 2026426042773048
Q3 2025356941372603
YTD 202611496113948356
YTD 20257941108375700
USD millions; year-to-date spans 36 weeks.

Earnings quality and working capital

The quality question is broader than whether an adjustment is technically allowed. Restructuring is excluded from core income but requires cash. Commodity marks may reverse through future inventory costs. Acquisition-credit timing can benefit GAAP results without improving cash generation. Tariff refunds remain inside the current core result. These categories serve different purposes, and removing all of them mechanically would create another arbitrary profit definition.

Year-to-date stock compensation was $240 million, only 0.35% of revenue. Minority leakage is also modest. Those are favorable features. The larger cautions are the repeated cost-reduction program, the weaker North American margin trajectory and the gap between accounting earnings and cash after investment. Working-capital proxies are calculated using closing balances and the quarter’s sales or cost base. They are deliberately labeled proxies because averages, country mix and monthly international calendars would improve the precision.

Receivables increased from $11.506 billion at year-end to $13.623 billion, and inventory rose from $5.845 billion to $6.434 billion. Some increase is seasonal as the business moves through the year. The cash-flow statement confirms a material working-capital use, but a single end-point ratio cannot establish channel stuffing or excess inventory. We will look for cash conversion over the full fiscal year before treating the balance increase as a structural deterioration. Likewise, the provider’s statement classifications are cross-checked against primary statements: the packet retains actual GAAP operating profit rather than a vendor field that can omit a separately displayed impairment.

✔ CleanSBC / sales
0.35% YTD
Small relative to sales; still a real ownership cost.
▲ WatchGAAP/core gap
$17m net operating gap
Large offsetting adjustments make the net gap misleading.
▲ WatchBelow operations
$356m expense
Pension plus net interest/other; monitor financing burden.
✔ CleanMinority leakage
0.72% of net income
Computed Q3 minority share; small.
▲ WatchCash conversion
69.0% simple FCF / GAAP NI
YTD comparison is seasonal; not issuer core conversion.
▲ WatchReceivables
45.3 days
Period-end balance over 84-day sales; proxy, not company KPI.
▲ WatchInventory
46.9 days
Period-end inventory over 84-day cost of sales.
✔ CleanEffective tax
21.4%
Computed GAAP quarterly tax rate.
✖ FlagGuidance record
2026 EPS range reduced
Revenue strength has not protected domestic margin.
Working-capital proxies · Computed using 84 days for Q1–Q3 and 112 days for Q4; closing balances, no annualization of growth.
ReceivablesInventory
4045505560Q3 2024 · Receivable days: 44Q4 2024 · Receivable days: 42Q1 2025 · Receivable days: 51Q2 2025 · Receivable days: 46Q3 2025 · Receivable days: 44Q4 2025 · Receivable days: 44Q1 2026 · Receivable days: 53Q2 2026 · Receivable days: 47Q3 2026 · Receivable days: 4545Q3 2024 · Inventory days: 46Q4 2024 · Inventory days: 45Q1 2025 · Inventory days: 60Q2 2025 · Inventory days: 53Q3 2025 · Inventory days: 46Q4 2025 · Inventory days: 48Q1 2026 · Inventory days: 60Q2 2026 · Inventory days: 51Q3 2026 · Inventory days: 4747Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
4045505560Q3 2024 · Receivable days: 44Q4 2024 · Receivable days: 42Q1 2025 · Receivable days: 51Q2 2025 · Receivable days: 46Q3 2025 · Receivable days: 44Q4 2025 · Receivable days: 44Q1 2026 · Receivable days: 53Q2 2026 · Receivable days: 47Q3 2026 · Receivable days: 4545Q3 2024 · Inventory days: 46Q4 2024 · Inventory days: 45Q1 2025 · Inventory days: 60Q2 2025 · Inventory days: 53Q3 2025 · Inventory days: 46Q4 2025 · Inventory days: 48Q1 2026 · Inventory days: 60Q2 2026 · Inventory days: 51Q3 2026 · Inventory days: 4747Q32024Q12025Q32025Q12026Q32026
Show the data
QuarterReceivable daysInventory days
q3-202443.545.6
q4-202441.745.1
q1-202550.660.0
q2-202545.852.9
q3-202544.346.1
q4-202543.947.7
q1-202652.659.9
q2-202646.951.1
q3-202645.346.9
Three years of cash generation · Simple FCF = OCF less capex. Issuer FCF additionally includes property disposal proceeds.
Operating cashSimple FCF
05,00010.0K15.0K2023 · Operating cash: $13,442M2023 · Simple free cash: $7,924M2024 · Operating cash: $12,507M2024 · Simple free cash: $7,189M2025 · Operating cash: $12,087M$12,087M2025 · Simple free cash: $7,672M$7,672M202320242025
05,00010.0K15.0K2023 · Operating cash: $13,442M2023 · Simple free cash: $7,924M2024 · Operating cash: $12,507M2024 · Simple free cash: $7,189M2025 · Operating cash: $12,087M$12,087M2025 · Simple free cash: $7,672M$7,672M202320242025
Show the data
YearOCFCapexSimple FCFIssuer FCF
202313442.05518.07924.08122
202412507.05318.07189.07531
202512087.04415.07672.08200

Cash, debt and the dividend

The balance sheet contains $10.675 billion of cash and $488 million of short-term investments against $51.881 billion of short- and long-term debt. That is $40.718 billion of net debt on our liquid-assets definition. Investments in noncontrolled affiliates are not included as cash: their realization depends on market value, liquidity, strategic relationships and taxes. Debt is manageable for a diversified staple franchise, but it consumes part of the economic cushion that a gross-cash figure can imply.

Operating cash flow for the first 36 weeks was $7.950 billion. Subtracting $2.182 billion of capital expenditure gives $5.768 billion of simple free cash flow; adding $89 million of property sales gives the issuer’s $5.857 billion measure. Neither is cash available without obligations. Debt service, dividends and other commitments remain. Management continues to target at least 80% full-year free-cash-flow conversion against core net income, which is a different denominator from the GAAP comparison in our quality scorecard.

The annualized dividend is $5.92 per share. That implies a 4.68% yield at the observed quote, but future payments remain subject to board decisions. In 2025, dividends of $7.638 billion and buybacks of $1 billion exceeded issuer free cash flow of $8.2 billion by $438 million. This was not an enormous gap, but it means repurchases were not simply surplus internally generated cash. The 2026 cash-return plan stays at $8.9 billion. A stronger cash finish is therefore more valuable than an additional promise about cost savings. The newly authorized $10 billion repurchase program is capacity, not a guarantee that those shares will be bought immediately.

Equity price and financing claims
Market capitalizationMarket capitalization: $172,705M$172,705MGross debtGross debt: $51,881M$51,881MCash plus short investmentsCash plus short investments: $11,163M$11,163MNet debtNet debt: $40,718M$40,718M
Market capitalizationMarket capitalization: $172,705M$172,705MGross debtGross debt: $51,881M$51,881MCash plus short investmentsCash plus short investments: $11,163M$11,163MNet debtNet debt: $40,718M$40,718M
Show the data
Claim$m
Market cap172,705.4
Debt51881
Cash + short investments11163
Net debt40718
Net debt across nine quarter ends · Computed from retained statement balances; excludes noncontrolled affiliate investments from liquid cash.
020.0K40.0K60.0KQ3 2024 · Net debt across nine quarter ends: $36,963MQ4 2024 · Net debt across nine quarter ends: $35,682MQ1 2025 · Net debt across nine quarter ends: $39,936MQ2 2025 · Net debt across nine quarter ends: $43,411MQ3 2025 · Net debt across nine quarter ends: $42,188MQ4 2025 · Net debt across nine quarter ends: $40,371MQ1 2026 · Net debt across nine quarter ends: $41,900MQ2 2026 · Net debt across nine quarter ends: $42,498MQ3 2026 · Net debt across nine quarter ends: $40,718M$40,718MQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
020.0K40.0K60.0KQ3 2024 · Net debt across nine quarter ends: $36,963MQ4 2024 · Net debt across nine quarter ends: $35,682MQ1 2025 · Net debt across nine quarter ends: $39,936MQ2 2025 · Net debt across nine quarter ends: $43,411MQ3 2025 · Net debt across nine quarter ends: $42,188MQ4 2025 · Net debt across nine quarter ends: $40,371MQ1 2026 · Net debt across nine quarter ends: $41,900MQ2 2026 · Net debt across nine quarter ends: $42,498MQ3 2026 · Net debt across nine quarter ends: $40,718M$40,718MQ32024Q42024Q12025Q22025Q32025Q42025Q12026Q22026Q32026
Show the data
PeriodValue
Q3 202436,963.00
Q4 202435,682.00
Q1 202539,936.00
Q2 202543,411.00
Q3 202542,188.00
Q4 202540,371.00
Q1 202641,900.00
Q2 202642,498.00
Q3 202640,718.00
Cash allocation ($m)202320242025
Operating cash13442.012507.012087.0
Capital expenditure5518.05318.04415.0
Stock compensation380.0362.0288.0
Cash dividends6682.07229.07638.0
Common repurchases1000.01000.01000.0

Three routes, one modest cushion

Our call is HOLD with conviction three out of five and medium uncertainty. The rounded fair-value anchor is $135, with an illustrative $110–$160 range. The stock has approximately 6.8% price upside to the anchor from the observed quote. That is not enough to call the margin of safety compelling while North America’s profit recovery remains unproven. A price near $115 would provide roughly 15% discount to the same anchor, provided the operating thesis had not deteriorated.

The earnings route starts with actual 2025 core EPS of $8.14 and management’s revised 3% midpoint growth, giving $8.3842. A judgmental sixteen-times multiple yields $134.15. This multiple recognizes durable brands and distribution, but stops short of paying a premium growth valuation for an earnings stream whose outlook has been reduced. The normalized EPS choice includes management’s current assumptions; it is not a claim that every adjustment will disappear.

The cash route uses a prospective $8.5 billion equity cash-flow base, after capital expenditure and with financing held broadly stable. It assumes 4% growth for five years, an 8% equity discount rate and 3% perpetual growth. The present value is $133.86 per diluted share using 1.367 billion shares. This is an equity cash-flow model, so subtracting debt again would double count financing. The $8.5 billion starting cash flow is our normalized assumption, above 2025 issuer free cash flow but below what a strong conversion of guided earnings could support. It is not a reported number.

The dividend route treats the current $5.92 annualized dividend as the first projected annual payment, with no initial step-up, and capitalizes it using a 7.5% required return and 3% long-run growth, producing $131.56. Because it excludes any separate repurchase value, this serves as an income-oriented cross-check. Both discount models are sensitive to the small difference between discount and terminal growth rates. Their convergence is conditional on those choices; it is not independent proof of precision.

At the observed price, the equity cash-flow model requires a starting normalized cash flow of about $8.03 billion under the same growth and discount assumptions. That is close to recent issuer free cash flow, so the market is not demanding a spectacular acceleration. It is still asking the business to sustain that cash generation while maintaining investment and its dividend. The reverse case explains why we are not bearish, while the small valuation discount explains why we are not upgrading to BUY.

1

Earnings route

$8.14 × 1.03 × 16 = $134.15.

2

Equity cash-flow route

$8.5bn normalized start; 4% five-year growth; 8% discount; 3% terminal growth; ÷ 1.367bn shares = $133.86.

3

Dividend route

$5.92 ÷ (7.5% − 3.0%) = $131.56.

Core earnings and valuation multiple sensitivity · All cells computed; scenarios are assumptions, not price targets supplied by management.
Multiple14×16×18×20×$8.00 EPS$112.00$112.00$128.00$128.00$144.00$144.00$160.00$160.00$8.40 EPS$117.60$117.60$134.40$134.40$151.20$151.20$168.00$168.00$8.80 EPS$123.20$123.20$140.80$140.80$158.40$158.40$176.00$176.00Core EPS
Multiple14×16×18×20×$8.00 EPS$112.00$112.00$128.00$128.00$144.00$144.00$160.00$160.00$8.40 EPS$117.60$117.60$134.40$134.40$151.20$151.20$168.00$168.00$8.80 EPS$123.20$123.20$140.80$140.80$158.40$158.40$176.00$176.00Core EPS
Show the data
Core EPS14×16×18×20×
8112.00128.00144.00160.00
8.4117.60134.40151.20168.00
8.8123.20140.80158.40176.00
Cash model yearProjected equity cash flow $m
18,840.00
29,193.60
39,561.34
49,943.80
510,341.55
Terminal value uses year-five cash flow × 1.03 / (0.08 − 0.03).

Wall Street: aligned rating, lower value

The retained consensus rating is Hold: one strong buy, thirteen buys, thirty-one holds and one sell. Its average target is $145.25, with a $133–$176 range. We agree with the broad rating but use a lower $135 anchor. The difference reflects how much domestic recovery we are willing to capitalize before it appears in recurring profit and cash. A consensus target is an aggregation of different dates, horizons and methods, not a single freshly recalculated valuation.

The latest retained target-news item is RBC Capital’s October 6 reduction to $150 from $161. UBS was at $145 on October 2, Barclays at $133 on October 1 and Evercore ISI at $135 on September 30. These all precede the October 8 release. We therefore do not say analysts have already endorsed the revised earnings outlook. The provider’s 2026 EPS consensus near $8.54 is above the updated guidance-derived midpoint near $8.38; that gap is a revision risk, not proof of a future miss.

For 2027, the retained revenue estimate is approximately $101.58 billion and EPS $8.89, with different analyst counts for each metric. Farther-out estimates carry thinner coverage. Comparing these forecasts with management’s current-year targets is useful for identifying expectations, but treating the vendor’s annual net-income and EPS estimates as a fully reconciled GAAP forecast would overstate their consistency. We retain the original fields and counts so readers can evaluate the coverage themselves.

Consensus ratings on record
010203040Strong buy · Consensus ratings on record: 1Buy · Consensus ratings on record: 13Hold · Consensus ratings on record: 31Sell · Consensus ratings on record: 1Strong sell · Consensus ratings on record: 00Strong buyBuyHoldSellStrong sell
010203040Strong buy · Consensus ratings on record: 1Buy · Consensus ratings on record: 13Hold · Consensus ratings on record: 31Sell · Consensus ratings on record: 1Strong sell · Consensus ratings on record: 00StrongbuyBuyHoldSellStrongsell
Show the data
PeriodValue
Strong buy1.00
Buy13.00
Hold31.00
Sell1.00
Strong sell0.00
DateFirmTarget
2026-10-06RBC Capital$150
2026-10-02UBS$145
2026-10-01Barclays$133
2026-09-30Evercore ISI$135
2026-09-29Jefferies$138
2026-09-28Cowen & Co.$133
2026-09-28Deutsche Bank$138
2026-09-23BNP Paribas$161
FMP target news; listed observations precede Oct 8 results.
Consensus EPS versus revised 2026 guide · Management guide midpoint computed from 2025 core EPS; provider consensus may be stale.
2026 guide midpoint2026 guide midpoint: $8.38$8.382026 consensus2026 consensus: $8.54$8.542027 consensus2027 consensus: $8.89$8.89
2026 guide midpoint2026 guide midpoint: $8.38$8.382026 consensus2026 consensus: $8.54$8.542027 consensus2027 consensus: $8.89$8.89
Show the data
BasisEPS
2026 revised guide midpoint8.38
2026 consensus8.54
2027 consensus8.89
YearRevenue $bnEBIT $bnNet income $bnEPSRevenue/EPS analysts
202698.9115.5411.708.5416/12
2027101.5816.1112.158.8917/13
2028104.8816.9212.809.3715/6

Management: judge the conversion

Management’s language has become more explicit about the domestic repair taking longer than planned. We credit the international execution, organic-volume improvement and willingness to invest in affordability. We are less persuaded by savings programs until the savings become profit after the additional marketing and innovation expenditure required to sustain growth. A cost reduction that is fully reinvested may protect competitiveness without lifting the near-term earnings base.

Portfolio changes add promising products and exposure to functional hydration, zero sugar and newer snacking preferences. They also add integration costs, contingent consideration and the risk of paying for growth that could have been built more cheaply. The current release’s acquisition credits reinforce the need to distinguish purchase-accounting outcomes from customer demand. Neither a popular product nor a retail-sales headline guarantees an adequate return on invested capital.

Capital allocation remains shareholder-friendly in its intent, with an increased annualized dividend and planned repurchases. The test is whether internally generated cash funds those choices after maintaining plants, distribution and brands. We would ask management to quantify how much of the next margin improvement comes from sustainable operations versus asset sales, refunds or changes in acquisition liabilities. That reconciliation would be more useful than another broad productivity ambition.

Promise or actionEvidence this quarterAssessment
Accelerate organic growth3.1% consolidated; 8% internationalProgress
Repair North AmericaFood core margin −280 bpsNot yet demonstrated
Deliver prior EPS range2026 core CC range reducedMissed prior trajectory
Protect cash returns$8.9bn plan unchangedRequires full-year cash execution
Fund growth with savingsFurther structural actions identifiedFuture benefit, not booked value
  1. What domestic volume and price mix will restore profit without another affordability reset?
  2. How much tariff-refund or asset-sale benefit should investors expect to recur?
  3. What share of incremental productivity savings must fund brand investment?
  4. Can cash returns be funded without increasing leverage through the cycle?
  5. What acquisition return thresholds and contingent-payment outcomes will be disclosed?

The strongest bull and bear cases

The bull case is credible: leading brands, a broad distribution system and international growth can finance a domestic reset. Better value, innovation and functional categories may rebuild volumes. If domestic margin erosion slows while international growth persists, the stock could deserve a higher earnings multiple even before growth returns to its old pace. The dividend also returns cash while that process unfolds.

The bear case is that a low-growth consumer business now needs persistently more spending to defend its position. Lower-price packs may stabilize units but cap revenue per unit, and advertising can become a permanent cost rather than a temporary repair investment. Currency and acquired revenue can obscure that problem. A balance sheet with meaningful net debt and a large dividend commitment leaves less room for error if cash conversion weakens.

Our middle case gives value to the franchise without assuming a rapid domestic rebound. Medium uncertainty means we demand a visible price cushion or stronger recurring evidence before buying. The $110 bear scenario is illustrative, not a floor; a severe recession, execution failure or lasting loss of brand relevance could produce worse outcomes. Conversely, the $160 bull scenario requires both an earnings recovery and a higher multiple. It should not be described as a likely return simply because it appears in a chart.

RiskLikelihoodImpactWhat we watch
Domestic pricing/volume trade-offHighHighOrganic growth plus core margin together
Commodity and tariff volatilityHighMediumRefunds separated from recurring costs
FX translation reversalMediumMediumConstant-currency versus reported growth
Acquisition return/integrationMediumHighOrganic growth, cash costs and write-downs
Dividend funding/leverageMediumHighFull-year FCF versus cash returns
Customer concentrationMediumHighWalmart/affiliates were 14% of 2025 sales
Health preferences and competitionHighHighPortfolio relevance and unit share

What changes the decision

The next financial results are the principal checkpoint, but no exact date is asserted here without an issuer announcement. Provider calendars currently point to early February 2027; that estimate can change. In the meantime, announced cost actions, brand investments and cash distributions can inform the thesis, but they do not replace consolidated evidence. We would rather miss the first increment of a rebound than capitalize a margin recovery that remains a plan.

Our entry checkpoint is also conditional. A fall to $115 does not mechanically make the stock a BUY if the earnings base or cash generation has simultaneously deteriorated. Conversely, improved domestic margins and positive refund-adjusted profit growth could justify revisiting the fair-value assumptions even at a higher price. The point of the signposts is to connect an observable business result to a change in the decision. They are not a trading calendar or a promise to issue a recommendation on a preset date.

TimingEventDecision relevance
Q4 2026 / coming monthsStructural cost actions beginNet savings after growth investment
FY2026 results; issuer date pendingCash flow and updated outlookGuidance credibility and dividend funding
Next quarterNorth America margin/volumeEvidence of economic repair
Every quarterInternational organic growthWhether the offset remains durable
OngoingPrice near $115Reassess with unchanged or better fundamentals

Data, sources and methods

The research uses nine original quarterly releases from Q3 2024 through Q3 2026, the latest quarterly and annual SEC filings, prepared management remarks and timestamped FMP market datasets. All derived ratios, bridges and valuation arithmetic are calculated in the saved data builder. Monetary statement figures are in US dollars; this packet does not introduce a currency conversion. Core measures are PepsiCo’s non-GAAP definitions and must be read with the retained reconciliations.

Historical quarterly tables retain the original releases rather than silently stitching together revised segment labels. The company moved from seven operating segments to six; the current year-on-year segment comparisons use the comparable figures supplied in the latest release. Q4 includes a longer reporting period than the other quarters, and international businesses use monthly calendars. Straight sequential comparisons can therefore mislead. Annual cash-flow totals are more suitable for funding analysis than multiplying one quarter by four.

Simple free cash flow means operating cash flow less capital expenditure. PepsiCo’s free cash flow adds proceeds from sales of property, plant and equipment. Net debt subtracts cash and short-term investments from reported debt; it does not subtract strategic equity holdings. EPS valuation uses diluted weighted-average shares where appropriate, while provider market capitalization uses its contemporaneous share basis. Working-capital days use period-end balances and are proxies. Scenario probabilities, multiples, discount rates, terminal growth and the normalized cash-flow base are editorial assumptions, not management forecasts.

The remaining uncertainty is ordinary forecasting uncertainty, not a claim that the public filings are incomplete. The exact release clock was not independently confirmed; the issuer had announced approximately 5 a.m. Central. SEC acceptance timestamps are retained separately and are not used as the market release time. Current price and consensus observations were collected after publication of the results, but the underlying analyst inputs may still reflect earlier views. A future revision to those inputs should be evaluated as new information, not retrospectively inserted into this dated decision.

Quarter$m revenue$m GAAP op$m core opGAAP EPSCore EPS
q3-202423,3193,8724,1762.132.31
q4-202427,7842,2503,4621.111.96
q1-202517,9192,5832,7891.331.48
q2-202522,7261,7893,9110.922.12
q3-202523,9373,5694,1371.902.29
q4-202529,3433,5574,0751.852.26
q1-202619,4433,2133,0501.701.61
q2-202624,1814,0234,0672.182.20
q3-202625,2744,2604,2772.232.34
QuarterPensionInterest/otherTaxMinoritiesParent income
q3-202441−219749152,930
q4-2024−177−264275111,523
q1-202523−26449991,834
q2-202542−260292161,263
q3-202526−264713152,603
q4-2025−224−333445152,540
q1-202658−301632112,327
q2-202659−230848232,981
q3-2026−114−242834223,048
USD millions; signed pension and interest rows follow primary presentation.
YearEmployeesSBC $mDividends $mBuybacks $m
2023318,000380.06682.01000.0
2024319,000362.07229.01000.0
2025306,000288.07638.01000.0